Randy Jensen M.D. Ph.D.

Neurosurgery

E-mail: randy.jensen@hsc.utah.edu
Address: 4342 HCI
Phone: 581-6550

Research Title: Inhibition of HIF-1 by siRNA in an intracranial brain tumor
model


Research description:  Hypoxia inducible factor-1 is the principle regulator of vascular endothelial growth factor (VEGF) which is  presumed  to be the principal mediator of angiogenesis and peritumoral edema in human Glioblastoma multiforme.  We have used RNA interference (RNAi) to significantly reduce HIF-1 levels in U251 glioma cells grown in vitro and in vivo.  In vitro, growth was attenuated using small interfering RNAs (siRNA) and constitutively using short hairpin RNAs (shRNA).  Intertumoral injection of siRNA against HIF-1 effectively curbed tumor growth. As proof of principle, these studies were conducted in a single glioma cell line and in a flank brain tumor model. Unfortunately,before these results to be applied to the clinical situation further studies need to be done in other glioma cell lines in in an intracranial model.


Does this research involve human subjects or animals?

If yes, what is the protocol number?  04-10010

10/06


Faculty Submissions | Research Opportunities | Written Instructions | Medical Student Research Program Home